You’re Already Too Late, Unless You’re Already on the List
Most sales reps spend countless hours refining their pitch. The delivery, the deck, the objection handling. All of it carefully rehearsed. But what if the pitch is rarely what actually wins the deal?
That’s the uncomfortable conclusion from the 2026 B2B Buyer Behavior Report by Consensus. They found that 80% of B2B decision-making happens before a seller ever enters the room. Which raises the question: if the shortlist is already built before you call, how do you get on it?
The Shortlist Is Built Before You Call
The data is consistent across multiple research sources and leaves little wiggle room. According to 6Sense, 95% of the time, the vendor that wins a deal was already on the buyer’s Day One shortlist. Not discovered during the sales process. Not won over by a compelling presentation. Already there, before the first conversation ever happened.
It goes further. 94% of buying groups rank their preferred vendors in order of preference before initiating any contact with sales. 81% have effectively chosen their vendor before a rep is ever involved. Buyers don’t approach purchasing decisions as blank slates—they arrive with names they already know, already trust, and already intend to buy from. The rep who sits back and waits for inbound interest isn’t just being passive. They’re often chasing a race they didn’t finish.
Prior Experience Is the Real Shortlist Currency
Here’s the detail that makes this particularly sharp for anyone in clinical sales. Of the vendors that make it onto the average shortlist, 3.8 out of 5 have prior personal experience with the buyer. Not brands they’ve heard of. People and companies they’ve actually worked with before.
Hospital buyers remember the reps who showed up when something went wrong, who understood the workflow pressure at 2 AM, who didn’t disappear after the contract was signed. That kind of track record doesn’t reset when a rep changes companies.
Across his career at Ecolab, ThermoFisher Scientific, and now Radiometer, Tyler Eppes has been building exactly this kind of compounding trust—the sort that follows a rep from account to account and institution to institution. Clinicians move between hospital systems. When they do, they bring their preferences with them.
The Invisible Journey You’re Not Seeing
Buyers spend nearly three-quarters of their purchasing journey researching anonymously. No form fills, no demo requests, no signals in a CRM. Just quiet, independent evaluation—consuming up to 15 pieces of content before they ever make contact with a vendor. By the time 83% of buyers do reach out, they’ve already defined exactly what they need and who they want to provide it.
What shapes that invisible phase? Thought leadership. LinkedIn presence. Peer recommendations. Industry reputation. Conference visibility. The reps and companies that show up consistently in those spaces get considered. The ones that don’t, don’t. Absence during this phase isn’t neutral—it’s effectively a disqualification.
How to Win Before the Call
Tyler Eppes knows that the job starts long before the buyer knows they’re buying. The practical work of clinical sales is less about perfecting a pitch and more about building trust before the pitch. That means:
- showing up consistently—at industry conferences, LinkedIn conversations, etc
- investing in relationships with no immediate return
- using content and thought leadership to stay visible
- going deep into existing contacts rather than chasing volume through cold outreach
The reps winning in 2026 aren’t necessarily the sharpest closers in the room. They’re the ones who were already on the list.
Leave a Reply